September 14, 2017 TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (FR0011072602 – ALVXM / PEA‐PME) (Paris:ALVXM), a medical device company specializing in the minimally-invasive treatment of vertebral fractures, announces its consolidated results for the first half of 20172 in line with guidance3. “Our sales performance and controlled expenses for the first half of […]